Notícias

Howmet Aerospace has delivered very strong share price gains over the past five years, while both an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and market multiples currently point to an expensive stock. For investors, the question is whether the recent price leaves enough room for error if expectations ease. Howmet Aerospace has returned roughly 7.6x over 5 years, which puts extra focus on whether the current price already reflects most of the good news that...

NXP Semiconductors stock has delivered a 14.9% total return over the past 5 years, yet current valuation checks suggest the shares may still trade below a conservative view of intrinsic value. The Discounted Cash Flow (DCF) estimate and market multiple comparison both point to the stock pricing in a discount of around 10.1% to those fair value markers. A 14.9% return over 5 years points to long term value creation, while the current market price still sits below the intrinsic value...

Earlier this year, Astera Labs, Inc. (ALAB) was highlighted for significantly outperforming its Computer and Technology peers, supported by improved earnings estimate trends and a top Zacks Rank of #1 (Strong Buy). This shift in analyst expectations and sentiment suggests the market is increasingly focused on Astera Labs’ earnings power as a core part of its AI connectivity story. Now we’ll examine how this stronger analyst sentiment around Astera Labs’ earnings outlook could reshape the...

Oscar Health (OSCR) recently reported record first half 2026 results and raised its full year guidance, a combination that appears to have supported renewed investor attention on the stock this month. At a share price of US$30.47, Oscar Health has seen some short term volatility, with a 7 day share price return down 4.9%. However, the 90 day share price return of 37.07% and 3 year total shareholder return of 363.07% suggest momentum has been strong over a longer stretch as investors react to...

Following historic performance, here’s what could happen to CRWD shares next.

Halliburton stock has nearly doubled over the past five years, and the current valuation checks still lean on the cheap side for a business that has already delivered strong medium term gains. A roughly 96.9% return over five years suggests Halliburton has already rewarded patient holders, so the question is how much of the story is now reflected in the price. The recently awarded bp contract for the Bumerangue field in Brazil can support investor confidence in Halliburton's technology led...

Elastic N.V. recently reported fiscal first-quarter 2027 results, with revenue rising to US$478.11 million and net loss narrowing to US$16.73 million, while also issuing guidance that points to continued revenue growth through fiscal 2027. Alongside the earnings beat and raised outlook, Elastic highlighted growing enterprise adoption of its AI-powered search and cloud platform, and disclosed that non-executive director Caryn Marooney will step down after her term ends in October...

Chevron is getting in on the AI boom with its recent long-term energy agreement with Microsoft.

What General Dynamics' Q2 2026 Beat Tells Investors General Dynamics (GD) reported second quarter 2026 earnings of $4.24 per share, surpassing estimates, with revenue growth across all four segments and a reported backlog of $136.5b plus $50.4b in potential contract value. General Dynamics shares are trading at $379.32. Short term share price momentum has been slightly softer over the past week, while the 90 day share price return of 9.37% and 1 year total shareholder return of 18.93% point...

Bristol-Myers Squibb has delivered a strong 47.9% return over the past year, yet several valuation checks still frame the stock as cheap relative to an intrinsic value estimate and to market multiples. For investors, the question is whether the current share price reflects a genuine discount or simply the market catching up with earlier pessimism. The 47.9% gain over 1 year highlights how sharply sentiment toward Bristol-Myers Squibb has improved. This can reduce the margin of safety if...

Advanced Energy Industries has delivered a very strong run over the past five years, yet recent valuation checks suggest the stock now looks closer to fairly priced than clearly cheap. With the share price recently around US$272.82, the question for investors is how much of that past performance is already reflected in today’s valuation. Advanced Energy Industries has returned about 211.5% over the past five years, which puts recent gains into sharp focus when judging what is already priced...

Workday stock has delivered a weak result over the past 5 years, with the share price declining 26.3%, even as an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach points to the shares trading at a discount to that model. Set against that, market based checks on earnings and revenue multiples suggest pricing that looks broadly in line with peers rather than clearly cheap. The 26.3% share price decline over 5 years leaves Workday trailing many large software peers, which...

Earlier in 2026, Oscar Health reported record first-half financial results and lifted its full-year guidance, prompting analysts to raise their earnings estimates and highlight a low PEG ratio of 0.6 as evidence of relatively modest valuation expectations. This combination of upgraded guidance and analyst estimate revisions underscores how improving profitability expectations are reshaping perceptions of Oscar Health’s earnings power and growth profile. We’ll now examine how Oscar Health’s...

Amkor Technology stock has almost doubled over the past year, yet on broad valuation checks it still screens as relatively cheap. This raises a clear question about how much of the recent optimism is already reflected in the price. Over the past 12 months Amkor Technology has returned 99.6%, which puts recent enthusiasm in sharp contrast with where traditional valuation measures still place the stock. Interest in advanced semiconductor packaging, highlighted by recent commentary from Bank of...

Earlier this week, Hims & Hers Health reported quarterly revenue of US$753.2 million, up 38.2% year on year, added 307,000 customers to reach 2.89 million, and raised both next-quarter revenue guidance and full-year EBITDA guidance above analyst expectations. Alongside these financial updates, new survey findings on Gen Z sexual health attitudes and ongoing regulatory and legal scrutiny of Hims & Hers’ privacy and billing practices highlight both expanding demand for its services and...

TJX Companies has delivered strong share price gains over the past five years, yet the current valuation checks point to a stock that appears expensive on an intrinsic value basis while trading around fair on earnings-style multiples. Recent short-term share price weakness adds another consideration for investors who are weighing what they are paying today against what the current fundamentals can reasonably support. Over the past 5 years, TJX Companies has returned about 104.4%, which...

Best Buy Co., Inc. (NYSE:BBY) reported stronger fiscal second-quarter results. Revenue increased 3.6% year over year to $9.78 billion, while comparable sales rose 4.1% after increasing 1.6% a year earlier. Enterprise gross margin reached 23.9%, up from 23.2%. The composition of that margin improvement matters. The domestic gross profit rate increased 60 basis points to […]

Nutanix, Inc. (NASDAQ:NTNX) ended fiscal 2026 with a strong quarter, but its reported free cash flow guidance midpoint points to a more measured year ahead. Fourth-quarter revenue rose 16% to $757.1 million, while annual recurring revenue, or ARR, also increased 16% to $2.55 billion. Revenue exceeded Nutanix, Inc. (NASDAQ:NTNX)’s $725 million-$745 million guidance range and […]

In the second quarter of 2026, Valero Energy reported a large improvement in adjusted earnings per share and revenues, alongside rising consensus estimates and a top Zacks Rank #1 rating reflecting upgraded earnings expectations. The company’s constructive refining backdrop, marked by lower light-product inventories and constrained global refining capacity, is supporting expectations for stronger crack spreads and profitability, reinforced by a low PEG ratio relative to its industry and a...

Affirm Holdings (AFRM) is back in focus after fiscal fourth quarter results topped analyst expectations, with revenue rising 33% to $1.17b and gross merchandise volume reaching $14.1b, alongside guidance that outpaced forecasts. Affirm Holdings shares have picked up momentum into these results, with a 30 day share price return of 10.91% and a 90 day share price return of 5.58%. However, the 1 year total shareholder return is still down 12.10%, reflecting lingering risk concerns despite a 3...

Record $659M profit driven by strong tanker rates across vessel classes.

Marvell Technology (NasdaqGS:MRVL) reported strong quarterly results and raised near term and long term revenue guidance, yet the stock fell after the earnings release. The company lifted its fiscal 2027 and 2028 revenue outlook, pointing to building momentum in data center demand and AI related growth drivers. The post earnings share price reaction highlighted that investor expectations for AI exposure remain very high, even when companies report solid operational performance. For a...

SentinelOne (NYSE:S) reported second-quarter fiscal 2027 results that exceeded its guidance for revenue, operating income and earnings per share, as the cybersecurity company cited growth in artificial intelligence security, cloud and data offerings alongside continued endpoint demand. Revenue for

SentinelOne co-founder, chairman and CEO Tomer Weingarten discusses earnings and AI Cybersecurity in an interview with Romaine Bostick and Emily Graffeo on "The Close."

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the payment processing industry, including Fiserv (NASDAQ:FISV) and its peers.

A collapsing legacy business is hiding rapid AI momentum

Marvell Stock Crashes Below Key Support After 10% Selloff

Coca-Cola recently reported second-quarter 2026 results that exceeded revenue and earnings forecasts, driven by both volume gains and pricing, and raised its full-year outlook for organic growth and profitability. This stronger performance has been echoed by an analyst upgrade that emphasizes improving earnings prospects and reinforces confidence in Coca-Cola’s underlying business momentum. With the upgraded earnings outlook now in focus, we’ll explore how this stronger-than-expected quarter...

Marvell Technology (MRVL) stock fell 10% in Friday's trading session despite posting record Q2 results yesterday evening and raising its longer-term outlook.

The chipmaker beat on both lines Thursday, then watched its stock shed nearly 11% by Friday.